BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28875538)

  • 1. A generalized parametric response mapping method for analysis of multi-parametric imaging: A feasibility study with application to glioblastoma.
    Lausch A; Yeung TP; Chen J; Law E; Wang Y; Urbini B; Donelli F; Manco L; Fainardi E; Lee TY; Wong E
    Med Phys; 2017 Nov; 44(11):6074-6084. PubMed ID: 28875538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.
    Lundemann M; Munck Af Rosenschöld P; Muhic A; Larsen VA; Poulsen HS; Engelholm SA; Andersen FL; Kjær A; Larsson HBW; Law I; Hansen AE
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):603-613. PubMed ID: 30276440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
    Kickingereder P; Radbruch A; Burth S; Wick A; Heiland S; Schlemmer HP; Wick W; Bendszus M; Bonekamp D
    Radiology; 2016 May; 279(2):542-52. PubMed ID: 26579564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment.
    Galbán CJ; Lemasson B; Hoff BA; Johnson TD; Sundgren PC; Tsien C; Chenevert TL; Ross BD
    Tomography; 2015 Sep; 1(1):44-52. PubMed ID: 26568982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
    Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
    J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.
    Anwar M; Molinaro AM; Morin O; Chang SM; Haas-Kogan DA; Nelson SJ; Lupo JM
    Radiat Res; 2017 Sep; 188(3):303-313. PubMed ID: 28723274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.
    Galbán CJ; Chenevert TL; Meyer CR; Tsien C; Lawrence TS; Hamstra DA; Junck L; Sundgren PC; Johnson TD; Galbán S; Sebolt-Leopold JS; Rehemtulla A; Ross BD
    Clin Cancer Res; 2011 Jul; 17(14):4751-60. PubMed ID: 21527563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
    Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
    J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
    Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
    Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps.
    Reimer C; Deike K; Graf M; Reimer P; Wiestler B; Floca RO; Kickingereder P; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    PLoS One; 2017; 12(4):e0174620. PubMed ID: 28384170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating potential of multi-parametric MRI using co-registered histology: Application to a mouse model of glioblastoma.
    Al-Mubarak H; Vallatos A; Gallagher L; Birch J; Chalmers AJ; Holmes WM
    Magn Reson Imaging; 2022 Jan; 85():121-127. PubMed ID: 34687852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parametric Response Mapping of FLAIR MRI Provides an Early Indication of Progression Risk in Glioblastoma.
    Hoff BA; Lemasson B; Chenevert TL; Luker GD; Tsien CI; Amouzandeh G; Johnson TD; Ross BD
    Acad Radiol; 2021 Dec; 28(12):1711-1720. PubMed ID: 32928633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma.
    Li C; Wang S; Serra A; Torheim T; Yan JL; Boonzaier NR; Huang Y; Matys T; McLean MA; Markowetz F; Price SJ
    Eur Radiol; 2019 Sep; 29(9):4718-4729. PubMed ID: 30707277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.
    Ceschin R; Kocak M; Vajapeyam S; Pollack IF; Onar-Thomas A; Dunkel IJ; Poussaint TY; Panigrahy A
    J Neurooncol; 2019 May; 143(1):79-86. PubMed ID: 30810873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An augmented parametric response map with consideration of image registration error: towards guidance of locally adaptive radiotherapy.
    Lausch A; Chen J; Ward AD; Gaede S; Lee TY; Wong E
    Phys Med Biol; 2014 Nov; 59(22):7039-58. PubMed ID: 25360595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.
    Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A
    AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression based overall survival prediction of glioblastoma multiforme patients using a single discovery cohort of multi-institutional multi-channel MR images.
    Sanghani P; Ang BT; King NKK; Ren H
    Med Biol Eng Comput; 2019 Aug; 57(8):1683-1691. PubMed ID: 31104273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.